Logo image of EVA

ENVIVA INC (EVA) Stock Fundamental Analysis

NYSE:EVA - New York Stock Exchange, Inc. - US29415B1035 - Common Stock - Currency: USD

0.4198  +0.01 (+2.22%)

Fundamental Rating

2

EVA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 212 industry peers in the Oil, Gas & Consumable Fuels industry. EVA has a bad profitability rating. Also its financial health evaluation is rather negative. EVA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EVA has reported negative net income.
In the past year EVA has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: EVA reported negative net income in multiple years.
EVA had a positive operating cash flow in 4 of the past 5 years.
EVA Yearly Net Income VS EBIT VS OCF VS FCFEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M -200M -300M

1.2 Ratios

The Return On Assets of EVA (-11.74%) is worse than 89.00% of its industry peers.
Looking at the Return On Equity, with a value of -109.62%, EVA is doing worse than 93.30% of the companies in the same industry.
Industry RankSector Rank
ROA -11.74%
ROE -109.62%
ROIC N/A
ROA(3y)-3.96%
ROA(5y)-2.25%
ROE(3y)-28.14%
ROE(5y)-16.14%
ROIC(3y)N/A
ROIC(5y)N/A
EVA Yearly ROA, ROE, ROICEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40

1.3 Margins

EVA has a worse Gross Margin (1.44%) than 84.21% of its industry peers.
In the last couple of years the Gross Margin of EVA has declined.
The Profit Margin and Operating Margin are not available for EVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5Y-15.21%
EVA Yearly Profit, Operating, Gross MarginsEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10

More info and screens

2

2. Health

2.1 Basic Checks

EVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EVA has more shares outstanding
EVA has a better debt/assets ratio than last year.
EVA Yearly Shares OutstandingEVA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
EVA Yearly Total Debt VS Total AssetsEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B 2.5B

2.2 Solvency

EVA has an Altman-Z score of 0.16. This is a bad value and indicates that EVA is not financially healthy and even has some risk of bankruptcy.
EVA's Altman-Z score of 0.16 is on the low side compared to the rest of the industry. EVA is outperformed by 71.29% of its industry peers.
A Debt/Equity ratio of 5.83 is on the high side and indicates that EVA has dependencies on debt financing.
EVA's Debt to Equity ratio of 5.83 is on the low side compared to the rest of the industry. EVA is outperformed by 93.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.83
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACCN/A
WACC3.08%
EVA Yearly LT Debt VS Equity VS FCFEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.42 indicates that EVA should not have too much problems paying its short term obligations.
EVA's Current ratio of 1.42 is in line compared to the rest of the industry. EVA outperforms 59.33% of its industry peers.
EVA has a Quick Ratio of 1.06. This is a normal value and indicates that EVA is financially healthy and should not expect problems in meeting its short term obligations.
EVA has a Quick ratio (1.06) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.06
EVA Yearly Current Assets VS Current LiabilitesEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for EVA have decreased strongly by -68.50% in the last year.
The Revenue has decreased by -0.20% in the past year.
EVA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.04% yearly.
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.36%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y15.04%
Sales Q2Q%-1.55%

3.2 Future

Based on estimates for the next years, EVA will show a decrease in Earnings Per Share. The EPS will decrease by -3.17% on average per year.
The Revenue is expected to grow by 10.60% on average over the next years. This is quite good.
EPS Next Y-148.2%
EPS Next 2Y6.01%
EPS Next 3Y14.13%
EPS Next 5Y-3.17%
Revenue Next Year-6.05%
Revenue Next 2Y1.19%
Revenue Next 3Y11.72%
Revenue Next 5Y10.6%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EVA Yearly Revenue VS EstimatesEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
EVA Yearly EPS VS EstimatesEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVA Price Earnings VS Forward Price EarningsEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EVA is valued a bit more expensive than 79.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 94.98
EVA Per share dataEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

EVA's earnings are expected to grow with 14.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.01%
EPS Next 3Y14.13%

More info and screens

0

5. Dividend

5.1 Amount

EVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVIVA INC

NYSE:EVA (10/3/2024, 8:11:14 PM)

0.4198

+0.01 (+2.22%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)09-13 2024-09-13/amc
Earnings (Next)10-30 2024-10-30/amc
Inst Owners57.12%
Inst Owner Change0%
Ins Owners21.27%
Ins Owner Change0%
Market Cap31.43M
Analysts45
Price Target4.08 (871.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend3.3
Dividend Growth(5Y)6.05%
DP-32.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-143.34%
Min EPS beat(2)-288.14%
Max EPS beat(2)1.47%
EPS beat(4)1
Avg EPS beat(4)-199.08%
Min EPS beat(4)-288.14%
Max EPS beat(4)1.47%
EPS beat(8)1
Avg EPS beat(8)-988.96%
EPS beat(12)2
Avg EPS beat(12)-666.21%
EPS beat(16)4
Avg EPS beat(16)-503.85%
Revenue beat(2)0
Avg Revenue beat(2)-5.65%
Min Revenue beat(2)-9.42%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-16.16%
Min Revenue beat(4)-43.89%
Max Revenue beat(4)-1.88%
Revenue beat(8)1
Avg Revenue beat(8)-12.45%
Revenue beat(12)2
Avg Revenue beat(12)-9.32%
Revenue beat(16)3
Avg Revenue beat(16)-8.99%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.1
P/tB 0.15
EV/EBITDA 94.98
EPS(TTM)-4.23
EYN/A
EPS(NY)-1.58
Fwd EYN/A
FCF(TTM)-4.42
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS15.11
BVpS4.14
TBVpS2.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.74%
ROE -109.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.44%
FCFM N/A
ROA(3y)-3.96%
ROA(5y)-2.25%
ROE(3y)-28.14%
ROE(5y)-16.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.71%
GM growth 5Y-15.21%
F-Score3
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 5.83
Debt/FCF N/A
Debt/EBITDA 111.49
Cap/Depr 207.35%
Cap/Sales 23.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.06
Altman-Z 0.16
F-Score3
WACC3.08%
ROIC/WACCN/A
Cap/Depr(3y)226.42%
Cap/Depr(5y)192.31%
Cap/Sales(3y)21.08%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-936.36%
EPS Next Y-148.2%
EPS Next 2Y6.01%
EPS Next 3Y14.13%
EPS Next 5Y-3.17%
Revenue 1Y (TTM)-0.2%
Revenue growth 3Y16.93%
Revenue growth 5Y15.04%
Sales Q2Q%-1.55%
Revenue Next Year-6.05%
Revenue Next 2Y1.19%
Revenue Next 3Y11.72%
Revenue Next 5Y10.6%
EBIT growth 1Y43.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1305.49%
EBIT Next 3Y202.11%
EBIT Next 5Y141.9%
FCF growth 1Y-88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-167.89%
OCF growth 3YN/A
OCF growth 5YN/A